ACROX | ARANX | ACROX / ARANX | |
Total Expense Ratio | 1.26 | 1.28 | 98% |
Annual Report Gross Expense Ratio | 1.47 | 1.28 | 115% |
Fund Existence | 11 years | 11 years | - |
Gain YTD | 15.843 | 7.327 | 216% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 2500 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 91.4M | 1.4B | 7% |
Annual Yield % from dividends | 1.25 | 0.51 | 246% |
Returns for 1 year | 11.88 | 1.36 | 876% |
Returns for 3 years | 50.36 | 25.06 | 201% |
Returns for 5 years | 111.98 | 37.95 | 295% |
Returns for 10 years | 109.53 | 34.48 | 318% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VYMQX | 19.00 | 0.15 | +0.80% |
Voya Mid Cap Research Enhanced Index A | |||
GLCRX | 30.25 | 0.18 | +0.60% |
Goldman Sachs Large Cap Gr Insghts R | |||
GCVCX | 24.22 | 0.07 | +0.29% |
Goldman Sachs Large Cp Val Insghts C | |||
LHCVX | 18.65 | 0.05 | +0.27% |
Lord Abbett Health Care R6 | |||
POAGX | 47.89 | 0.07 | +0.15% |
PRIMECAP Odyssey Aggressive Growth |